Department of Special Investigation on Thursday warned pharmacies still stocking pseudoephidrine medicines in any form to return them to the pharmaceutical companies or face criminal charges.
The deadline for return was Wednesday at 4.30pm.
DSI chief Tharit Pengdit said the medicine would now be available only at hospitals and medical clinics.
The Food and Drug Administration (FDA) reported Thursday that 18,150,000 tablets and 11,260,000 millilitres of medicines had been returned and the FDA would call a meeting of pharmacy business operators on May 25 to set a new system of drugordering called “FDA Reporter”. This would record the purchase of medicine from its original point to the destination point with the FDA acting as mediator.